Ozempic (Semaglutide)

Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg is a glucagon-like peptide 1 (GLP-1) receptor agonist, and an injectable prescription medicine used:

• along with diet and exercise to improve blood sugar (glucose) in adult individuals with type 2 diabetes (T2D).
• to reduce the probability of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes (T2D) with known heart disease.

Limitations of Use: It is not known if Ozempic can be used in individuals who have had pancreatitis. This medicine is not for use in people with type 1 diabetes. It is not known if this medicinal product is safe and effective for use in children aged under 18 years.

Recommended Dosage: The initial recommended dosage of Semaglutide injection is 0.25 mg administered subcutaneously once a week for the first 4 weeks. This 0.25 mg dosage is intended for treatment initiation and does not provide significant glycemic control. After 4 weeks at the 0.25 mg dosage, the dosage should be increased to 0.5 mg once weekly. If further glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage can be increased to 1 mg once weekly. If additional glycemic control is still required after at least 4 weeks at the 1 mg dosage, the dosage may be increased to 2 mg once weekly. The maximum recommended dosage is 2 mg once weekly. The day of weekly administration may be changed if necessary, provided there is at least a 48-hour interval between doses.

If you miss a dose, take it as soon as you remember, provided it’s within 5 days of the missed dose. If more than 5 days have passed, skip the missed dose and continue with your regular dosing schedule on the next planned day. Afterward, resume your usual weekly dosing routine.

• Ozempic injection has been shown to cause thyroid C-cell tumors in rodents. It is unknown if it causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. Avoid using this drug in patients with a personal or family history of MTC or patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• There have been reports of acute pancreatitis in patients using this medicine. Monitor patients for signs and symptoms of pancreatitis. If pancreatitis is suspected, discontinue treatment and do not restart if pancreatitis is confirmed.
• The risk of hypoglycemia is increased when treatment with semaglutide 0.5 mg, 1 mg, or 2 mg is used together with insulin or an insulin secretagogue (e.g., sulfonylureas). Consider reducing the dose of the insulin secretagogue or insulin to lower the risk of hypoglycemia.
• In a clinical trial, more patients treated with Ozempic experienced diabetic retinopathy complications compared to patients treated with placebo. Monitor patients with a history of diabetic retinopathy accordingly.
• There have been reports of acute kidney injury and worsening chronic renal failure in patients taking GLP-1 receptor agonists, including Semaglutide. Monitor renal function when initiating or escalating doses of this therapeutic drug in patients with renal impairment.
• Serious hypersensitivity reactions, including anaphylaxis and angioedema, have been reported with Ozempic. If hypersensitivity reactions occur, discontinue treatment and treat promptly.

What documents are required to import OZEMPIC to India?

OZEMPIC (semaglutide) injections can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patient ID proof (issued by the government of India)

• The order will be confirmed only after the receipt of:
  
• A valid prescription from the Doctor
  
• Import permit if applicable

OZEMPIC (semaglutide injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Ozempic in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of OZEMPIC (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Ozempic price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source the OZEMPIC (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Ozempic®?

Semaglutide is a Generic Name for the trade name drug Ozempic®.

What is the Manufacturer’s Name of Ozempic®?

Ozempic® is manufactured by Novo Nordisk.

Is Ozempic® approved by the FDA?

Yes, Ozempic® is approved by the FDA. Date of first approval: December 5, 2017.

What is the dosage and form of Ozempic® supplied?

Ozempic (semaglutide) is supplied as a single-patient-use pen for subcutaneous injection in the following strengths:

• 2 mg/3 mL, delivering 0.25 mg or 0.5 mg per injection;
  
• 4 mg/3 mL, delivering 1 mg per injection;
  
• 8 mg/3 mL, delivering 2 mg per injection

The most common side effects of Ozempic are vomiting, diarrhea, nausea, abdominal pain, and constipation

How much does Ozempic® cost in India?

Prices may fluctuate over time due to market dynamics and regulatory changes. To obtain accurate and up-to-date information on the cost of Ozempic in India, it is recommended to Call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Where has Ozempic® (semaglutide) been approved?

Ozempic® (semaglutide) is approved for the treatment of type 2 diabetes (T2D) in the USA, EU, Canada, Japan, and Australia. However, this medicine is not approved for use as a weight loss medication in any country.

What are the storage conditions of Ozempic®?

Store Ozempic® (semaglutide)  in the refrigerator at 36°F to 46°F (2°C to 8°C). Protect from light; do not freeze.

Is it safe to buy Ozempic® online in India?

Yes, one can buy Ozempic online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Ozempic® through legal channels.